Position in MGNX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,015,257
+$960,225 QoQ
Shares Held
697,321
+6.4% QoQ
Ownership
1.10%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MGNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $18,583,356,554 across 528 Biotechnology names. MGNX ranks #269 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,139,621 | $2,741,586,360 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,607,732 | $2,014,838,051 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,660,385 | $880,241,584 | |
| 4 | INSM |
INSMED Inc
|
4,450,389 | $727,727,608 | |
| 5 | MRNA |
Moderna, Inc.
|
9,435,132 | $479,304,705 | |
| 6 | INCY |
Incyte Corp
|
4,703,184 | $442,663,677 | |
| 7 | RPRX |
Royalty Pharma plc
|
7,869,632 | $377,506,246 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
4,918,030 | $365,212,906 |
All Filings in MGNX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,015,257 | 697,321 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,055,032 | 655,300 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $1,104,634 | 657,521 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $827,080 | 683,538 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $1,849,357 | 1,456,188 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $4,657,955 | 1,433,217 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $4,628,621 | 1,406,876 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $6,014,765 | 1,415,239 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $21,079,231 | 1,432,013 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $13,507,134 | 1,404,068 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $6,151,200 | 1,320,000 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $6,430,785 | 1,202,016 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $8,343,700 | 1,163,696 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $7,577,891 | 1,129,343 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $3,627,854 | 1,048,513 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,024,549 | 1,025,271 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $8,717,838 | 989,539 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $16,351,114 | 1,018,761 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $21,819,584 | 1,042,005 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $28,115,731 | 1,046,751 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $30,163,574 | 947,051 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $20,223,533 | 884,669 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $19,783,444 | 785,369 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $20,817,319 | 745,606 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $4,327,274 | 743,518 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||